Search

everythinglearnresearchcommunity

for

Search:↓

Hair science has grown significantly, focusing on conditions like alopecia and improving treatments and techniques.

Gabapentin helps with scalp itch, dutasteride works for frontal fibrosing alopecia, and more research is needed for better PCA treatments.

Different types of hair loss have unique cellular changes, suggesting new treatment targets.

A rare case of a woman having both lichen planus pigmentosus and classic lichen planopilaris at the same time.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

Sunscreen use is linked to frontal fibrosing alopecia, especially in males.

Some types of hair loss can be reversed, others are permanent, and treatments vary by type.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

Some treatments that modify the immune system might help with certain types of hair loss but haven't been explored for common hair loss alone.

Various substances, including cosmetic sponges, vein glue, chai tea, skincare products, and medicaments, can cause allergic contact dermatitis, and healthcare workers often react to N95 masks.

Tacrolimus solution is effective and well-tolerated for treating inflammatory scalp conditions.

Use a 3-mm spot size and specific protective eyewear for safer and more effective laser treatment of facial veins.

Using facial sunscreen and moisturizer may increase the risk of frontal fibrosing alopecia.

A woman has a permanent hair loss condition treated with steroids and new medicines, but hair might not regrow.

Certain genes and proteins may help diagnose and treat primary cicatricial alopecia.

Lichen planopilaris causes permanent hair loss and scarring due to damage to hair follicles and can be mistaken for other hair loss conditions.

Lichen planopilaris in men often affects the scalp, eyebrows, arms, legs, and beard, with many having family members with hair loss.

Frontal Fibrosing Alopecia is a type of hair loss that mainly affects postmenopausal women, has unclear causes, and lacks evidence-based treatments.

Trichoscopy helps tell apart Lichen planopilaris and Frontal fibrosing alopecia from other hair loss conditions.

New hair treatment methods are evolving, with microneedling as a promising technique for hair growth.

The document highlights advancements and findings in dermatology, including AI use, disease prevention, treatment efficacy, and the impact of conditions on patients' lives.

Retinoids can both cause and treat different hair disorders.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

Frontal Fibrosing Alopecia mainly affects postmenopausal women and is linked to thyroid disease, hyperlipidemia, and anemia.

The document discusses hair and nail conditions, updates on treatments for alopecia, and controversies around finasteride use.

The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

The research found that certain characteristics like age, sex, race, marital status, and education level can influence whether alopecia patients stick to their hair loss treatment with topical minoxidil.

The document concludes that there have been significant advances in the treatment and diagnosis of various skin conditions.

FFA in young women is often missed, and no single treatment works best.